Search results for “Nucleoside X” companies
Free sign up to view the full data
Key Players
Order by:
Innovation Intensity
With the analysis among 714 patents, we discovered top 210 key players by total patent application. Ionis Pharmaceuticals, Inc., Gilead Sciences, Inc., Alios BioPharma, Inc. are dominant in this area. They take 14.01% of the total patent filing.
Ionis Pharmaceuticals, Inc.
California, United States
Patent: 40
Gilead Sciences, Inc.
California, United States
Patent: 32
Alios BioPharma, Inc.
California, United States
Patent: 28
Idenix Pharmaceuticals LLC
Massachusetts, United States
Patent: 21
Ajinomoto Co., Inc.
Tokyo-to, Japan
Patent: 18
F. Hoffmann-La Roche Ltd.
Switzerland
Patent: 14
Pharmasset, Inc.
New Jersey, United States
Patent: 14
MDRNA, Inc.
California, United States
Patent: 13
Medivir AB
Sweden
Patent: 12
RESprotect GmbH
Sachsen, Germany
Patent: 12
Startups & Unicorns
Order by:
Innovation Intensity
With the analysis among 5 patents, we discovered top 1 start-ups by total patent application.
STARTUP
Institut National de la Santé et de la Recherche Médicale
France
Patent: 5
Fast-Growing
Order by:
Innovation in recent 5 years
With the analysis among related 16 patents applied in the last 5 years. We discover 17 most active companies in this area. The fast-growing ModernaTX, Inc., Gilead Sciences, Inc., Roche Innovation Center Copenhagen A/S take 37.50% of patent filing during this period.
ModernaTX, Inc.
Massachusetts, United States
Patent: 3
Gilead Sciences, Inc.
California, United States
Patent: 2
Roche Innovation Center Copenhagen A/S
Hovedstaden, Denmark
Patent: 1
Janssen Pharmaceutica NV
Antwerpen, Belgium
Patent: 1
NuCana Plc
EDINBURGH, United Kingdom
Patent: 1
United States of America
United States
Patent: 1
Regents of The University of Michigan
Michigan, United States
Patent: 1
Eisai R&D Management Co., Ltd.
Tokyo-to, Japan
Patent: 1
Ercole Biotech, Inc.
North Carolina, United States
Patent: 1
Orga Bio Human Srl
CITY OF ROME, Italy
Patent: 1
New Entrants
Order by:
Innovation in recent 5 years
With the analysis among related 16 patents in last 5 years, we discover 6 new entrants. Ercole Biotech, Inc., Roche Innovation Center Copenhagen A/S, Orga Bio Human Srl are the most active new entrants in this area.
Ercole Biotech, Inc.
North Carolina, United States
Patent: 1
Roche Innovation Center Copenhagen A/S
Hovedstaden, Denmark
Patent: 1
Orga Bio Human Srl
CITY OF ROME, Italy
Patent: 1
The University of North Carolina at Chapel Hill
North Carolina, United States
Patent: 1
Hangzhou JLS Flame Retardants Chemical Co., Ltd.
Zhejiang Sheng, China
Patent: 1
Zhejiang University of Technology
Zhejiang Sheng, China
Patent: 1
Research Institutions
Order by:
Innovation Intensity
With the analysis among 142 patents, we discovered top 31 universities and scientific research institutions by total patent application. Emory University, University of Cagliari, University of Bern are dominant in this area. They take 38.03% of the total patent filing.
Emory University
Georgia, United States
Patent: 17
University of Cagliari
Sardegna, Italy
Patent: 10
University of Bern
Bern, Switzerland
Patent: 6
Yale University
Connecticut, United States
Patent: 5
University of Minnesota
Minnesota, United States
Patent: 3
Osaka University
Osaka-fu, Japan
Patent: 2
Dalian Institute of Chemical Physics Chinese Academy of Sciences
Liaoning Sheng, China
Patent: 2
Consejo Superior de Investigaciones Científicas
Madrid, Spain
Patent: 2
Shanghai Institute of Materia Medica Chinese Academy of Sciences
Shanghai Shi, China
Patent: 2
University of Rochester
New York, United States
Patent: 1
Keywords Quick Entry
Popular
Physics
Chemistry
Engineering
Materials science
Computer science
Biology
Medicine
MetalElectrodeVoltageSemiconductorPolymerElectricityCoatingFiberDisplay deviceRaw materialElectric motorUltimate tensile strengthNozzleCarbonBuilding constructionAlkylService lifeElectronOxideOxygenSolventControl unitFlangeControl systemDrugLight sourcePistonDiseaseElectric powerHigh pressure
View more
Page generation time: